| Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958) |
|---|
| 05/02/2001 | EP1095932A1 Phenoxyacetic acid derivatives and medicinal compositions containing the same |
| 05/02/2001 | EP1095027A1 Substituted phenyl uracils |
| 05/02/2001 | EP1095003A1 Cytokine production and tyrosine kinase inhibitors |
| 05/02/2001 | EP1094826A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors |
| 05/02/2001 | EP0743853B1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 05/01/2001 | US6225501 Optically active 2-aminotetraline, process for its preparation and pharmaceutical compositions containing same, active in preventing and treating septic shock |
| 05/01/2001 | US6225463 Reacting s-amine compound with an aldehyde; reacting with acyl chloride in presence of triethylamine to form diastereoisomeric beta-lactams; separation; treating with cerium ammonium nitrate and acetonitrile and water |
| 05/01/2001 | US6225352 Low molecular weight dendritic compounds as pharmaceutical agents |
| 05/01/2001 | US6224856 Means and method for tinting keratin fibers, particularly human hair |
| 04/25/2001 | EP1093450A1 Desformoterol and process for its preparation |
| 04/24/2001 | US6222073 Catalytic synthesis of N-alkylated anilines from olefins and anilines |
| 04/24/2001 | US6221954 Polyetherurethane copolymer |
| 04/24/2001 | US6221196 Wetting a support element in region of adhesion zone with liquid composition of adhesion promoter to form coating; solidifying coating; shaping and solidifying elastomeric material by vulcanization |
| 04/24/2001 | CA2025458C Iridium complexes, process for their preparation and their use |
| 04/19/2001 | WO2001027068A1 Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| 04/18/2001 | EP1092704A2 Bis (aminostyryl) naphtalene compounds, synthesis intermediates thereof, and process for production thereof |
| 04/18/2001 | EP1091965A1 Precursors for growth of heterometal-oxide films by mocvd |
| 04/17/2001 | US6218576 Process for producing a diarylamine |
| 04/17/2001 | US6218559 Hydrogenation catalyst, process for the preparation thereof and hydrogenation process |
| 04/17/2001 | CA2103044C Novel bi-aromatic compounds derived from a salicylic pattern, method of preparation and use in human and veterinary medicine and in cosmetics |
| 04/11/2001 | EP1090923A1 Process for the preparation of ruthenium hydrogenation catalysts and products thereof |
| 04/11/2001 | EP1090911A2 Bis(aminostyryl) anthracene compound, synthesis intermediate thereof, and process for production thereof |
| 04/11/2001 | EP1090905A1 Process for the preparation of ruthenium hydrogenation catalysts and products thereof |
| 04/11/2001 | EP1089961A1 Benflumetol derivatives, intermediates thereof and their use against parasitical protozoa and trematodes |
| 04/11/2001 | EP1089749A1 Novel therapeutic agents for membrane transporters |
| 04/10/2001 | US6214859 Psychological disorders; alzheimer's disorders; parkinson'sdisorders |
| 04/10/2001 | US6214481 Organic blue-emitting layer sandwiched between two electrodes |
| 04/10/2001 | US6214435 Aminium compounds and optical information recording media containing the same |
| 04/10/2001 | US6214253 Omega-hydrofluoroalkyl ethers, precursor carboxylic acids and derivatives thereof, and their preparation and application |
| 04/05/2001 | WO2001023497A1 Organic electroluminescent element |
| 04/05/2001 | WO2001023344A1 Amine compound and organic electroluminescence element using the same |
| 04/04/2001 | EP1087953A1 Nitrate salts of antihypertensive medicines |
| 04/04/2001 | EP1087943A1 Therapeutic biaryl derivatives |
| 04/04/2001 | EP1087934A1 Aminocyclohexyl ether compounds and uses thereof |
| 04/03/2001 | US6211245 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 04/03/2001 | US6211244 Aromatic amines for complexing calcium |
| 04/03/2001 | US6211234 Substituted phenyl compounds |
| 04/03/2001 | US6211228 Compositions and methods for treating mast-cell mediated conditions |
| 04/03/2001 | US6211214 Pesticides, insecticides or miticides |
| 03/29/2001 | WO2001021577A2 Melanin concentrating hormone antagonist |
| 03/29/2001 | WO2000059875A3 Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 03/29/2001 | CA2386474A1 Melanin concentrating hormone antagonist |
| 03/28/2001 | EP1086077A1 Novel antiestrogens, a method for the production thereof, and their pharmaceutical application |
| 03/28/2001 | EP1086066A1 Muscarinic receptor antagonists |
| 03/28/2001 | EP1086065A4 Combinatorial synthesis of multibinding libraries |
| 03/28/2001 | EP1086065A1 Combinatorial synthesis of multibinding libraries |
| 03/28/2001 | EP1085894A1 Beta 3-adrenergic receptor agonists |
| 03/28/2001 | EP1085890A1 Novel sodium channel drugs and uses |
| 03/28/2001 | EP1085889A2 Novel therapeutic agents that modulate endothelin receptors |
| 03/28/2001 | EP1085887A2 Novel angiotensin receptor modulators and their uses |
| 03/28/2001 | EP1085879A2 Multibinding agents that modulate the 5-ht transporter |
| 03/28/2001 | EP1085870A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 03/28/2001 | EP1085868A1 H1-histamine receptor antagonists |
| 03/28/2001 | EP1085847A2 Novel therapeutic agents that modulate estrogen receptors |
| 03/28/2001 | EP1035772A4 Fungicidal compositions and methods, and compounds and methods for the preparation thereof |
| 03/27/2001 | US6207669 In treatment of cancer and psoriasis |
| 03/22/2001 | WO2001019778A1 Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 03/22/2001 | WO1999063936A8 Novel therapeutic agents that modulate endothelin receptors |
| 03/21/2001 | EP1084103A1 New 3-aryl-2-hydroxypropionic acid derivative (i) |
| 03/21/2001 | EP1084102A1 New 3-aryl propionic acid derivatives and analogs |
| 03/21/2001 | EP1084101A1 New 3-aryl-2-hydroxypropionic acid derivative iii |
| 03/21/2001 | EP1084099A1 Process for the preparation of protected 3-amino-1,2-dihydroxypropane acetal and derivatives thereof |
| 03/21/2001 | EP1083921A1 Novel leukotriene receptor antagonists and their uses |
| 03/21/2001 | EP1083917A1 Novel analgesic agents |
| 03/21/2001 | EP1083893A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d 1? receptors |
| 03/21/2001 | EP1083889A2 Method for treating neurodegenerative disorders |
| 03/21/2001 | EP1083888A1 MULTIBINDING AGENTS THAT MODULATE PPARgamma AND RXR RECEPTORS |
| 03/21/2001 | CN1288001A Method for preparing high purity low E type tamoxifen or its citrate |
| 03/21/2001 | CN1287999A Method for preparing intermediate of methylsalfonamido phenethylamine derivative |
| 03/21/2001 | CN1063430C Ethanolamine derivatives |
| 03/20/2001 | US6204413 Process for the preparation of salts of 1-substituted 2,4-diaminobenzenes |
| 03/20/2001 | US6204299 Foaming agents used to prepare closed cell polyurethane foams |
| 03/15/2001 | WO2001017946A1 Tertiary alkyl alkoxylate derivatives and the composition thereof |
| 03/15/2001 | WO2001017945A1 Cationic alkyl alkoxylate derivatives |
| 03/15/2001 | DE19943636A1 Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 03/14/2001 | EP1082293A2 Formoterol polymorphs |
| 03/14/2001 | EP1082289A1 Methods for identifying novel multimeric agents that modulate receptors |
| 03/14/2001 | EP1082121A1 Hiv integrase inhibitors |
| 03/13/2001 | US6201025 For treatment of central nervous system disorders |
| 03/08/2001 | WO2001015684A2 Antimycotic drug |
| 03/08/2001 | WO2001015683A1 Delayed-action form of administration containing tramadol saccharinate |
| 03/08/2001 | WO2001015682A1 Pharmaceutical tramadol salts |
| 03/08/2001 | WO2001015667A1 Oral dosage forms |
| 03/08/2001 | WO1999063930A8 Novel angiotensin receptor modulators and their uses |
| 03/08/2001 | DE19937537A1 Substituierte 2-Dialkylaminoalkylbiphenyl-Derivate 2-substituted derivatives Dialkylaminoalkylbiphenyl |
| 03/08/2001 | CA2388560A1 Sustained-release form of administration containing tramadol saccharinate |
| 03/08/2001 | CA2381849A1 Antimycotic drug |
| 03/07/2001 | EP1080722A1 Antimycotic compositions |
| 03/07/2001 | EP1080163A1 Composition and method for radical polymerisation of ethylenically unsaturated monomers |
| 03/07/2001 | EP1080080A1 Novel therapeutic agents that modulate neurokinin receptors |
| 03/07/2001 | CN1062854C Salmeterol kinafoate with controlled particulate size |
| 03/06/2001 | US6197993 Prostaglandin e2 antagonists or agonists |
| 03/06/2001 | US6197920 Aromatic polyamideimide copolymers; heat resistance, mechanical properties |
| 03/06/2001 | US6197828 Derivatives of (+)-venlafaxine and methods of preparing and using the same |
| 03/06/2001 | US6197817 Phenylpropionic acids and esters: compounds and methods for inducing beta-blockade for the treatment of cardiac disorders |
| 03/01/2001 | WO2001014331A2 Non-quinoline inhibitors of malaria parasites |
| 03/01/2001 | WO2001014313A1 Novel amine and quaternary ammonium compounds made from ketones and aldehydes, and compositions containing them |
| 03/01/2001 | WO2001014299A1 Chiral ligands, transition-metal complexes thereof and uses thereof in asymmetric reactions |
| 03/01/2001 | DE19940740A1 Pharmazeutische Salze Pharmaceutical Salts |
| 03/01/2001 | CA2382779A1 Chiral ligands, transition-metal complexes thereof and uses thereof in asymmetric reactions |